Indications for and Barriers to Preemptive Kidney Transplantation: A Review

被引：21
作者：
Kallab, S. [1 ]
Bassil, N. [1 ]
Esposito, L. [1 ]
Cardeau-Desangles, I. [1 ]
Rostaing, L. [1 ,3 ]
Kamar, N. [1 ,2 ]
机构：
[1] CHU Rangueil, Dept Nephrol Dialysis & Organ Transplantat, F-31059 Toulouse 9, France
[2] CHU Rangueil, INSERM, U858, IFR BMT, F-31059 Toulouse 9, France
[3] CHU Purpan, INSERM, U563, IFR BMT, Toulouse, France
来源：
TRANSPLANTATION PROCEEDINGS | 2010年 / 42卷 / 03期
关键词：
LONG-TERM; SURVIVAL; DIALYSIS; ACTIVATION; RECIPIENTS; IMPACT; GRAFT;
D O I：
10.1016/j.transproceed.2010.02.031
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Preemptive kidney transplantation is the treatment of choice for end-stage renal disease. Compared with nonpreemptive transplantation, preemptive transplantation is significantly associated with improved kidney allograft survival in recipients of either cadaver or living-donor transplants. This seems to be related to better patient survival. It can be proposed to all patients, but still needs to be evaluated for repeat transplantation. The main barriers are organ-allocation policies and late referral of patients to transplantation centers.
引用
收藏
页码：782 / 784
页数：3
相关论文
共 16 条
[1]   Earlier is not necessarily better in preemptive kidney transplantation [J].
Akkina, S. K. ;
Connaire, J. J. ;
Snyder, J. J. ;
Matas, A. J. ;
Kasiske, B. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (10) :2071-2076
[2]  
DESCAMPSLATSCHA B, 1995, J IMMUNOL, V154, P882
[3]   Why do preemptive kidney transplant recipients have an allograft survival advantage? [J].
Gill, JS ;
Tonelli, M ;
Johnson, N ;
Pereira, BJG .
TRANSPLANTATION, 2004, 78 (06) :873-879
[4]   The role of pre-emptive re-transplant in graft and recipient outcome [J].
Goldfarb-Rumyantzev, AS ;
Hurdle, JF ;
Baird, BC ;
Stoddard, G ;
Wang, Z ;
Scandling, JD ;
Barenbaum, LL ;
Cheung, AK .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (05) :1355-1364
[5]   Preemptive living donor kidney transplantation: Do the benefits extend to all recipients? [J].
Innocenti, Giulio R. ;
Wadei, Hani M. ;
Prieto, Mikel ;
Dean, Patrick G. ;
Ramos, Eduardo J. ;
Textor, Stephen ;
Khamash, Hasan ;
Larson, Timothy S. ;
Cosio, Fernando ;
Kosberg, Kay ;
Fix, Lynette ;
Bauer, Charise ;
Stegall, Mark D. .
TRANSPLANTATION, 2007, 83 (02) :144-149
[6]   The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants [J].
Ishani, A ;
Ibrahim, HN ;
Gilbertson, D ;
Collins, AJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1275-1282
[7]   Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival [J].
Israni, AK ;
Feldman, HI ;
Propert, KJ ;
Leonard, M ;
Mange, KC .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (02) :374-382
[8]  
Kasiske BL, 2001, AM J TRANSPLANT, V1, P7
[9]   Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease [J].
Kaul, H ;
Girndt, M ;
Sester, U ;
Sester, M ;
Köhler, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :611-616
[10]   Early Living-Donor Kidney Transplantation: A Review of the Associated Survival Benefit [J].
Liem, Ylian S. ;
Weimar, Willem .
TRANSPLANTATION, 2009, 87 (03) :317-318
12